Rasdal Andrew P Insider Trades

Insider Trading History

Track insider trading activity for Rasdal Andrew P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Obalon Therapeutics
Obalon Therapeutics OBLN
President, CEO & Exec Chairman
Holding Value $504k 165,135 shares
Last Trade
Jun 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$159k 218,000 shares
$0.73
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Exec Chairman Of The Board
Holding Value $238k 77,892 shares
Last Trade
Aug 06, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$71.1k 21,875 shares
$3.25
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Exec Chairman Of The Board
Holding Value $1.99M 653,905 shares
Last Trade
Jan 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 86,957 shares
$23.00
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
President, CEO & Exec Chairman
Holding Value $1.73M 566,948 shares
Last Trade
Aug 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.92M 109,890 shares
$26.60
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
CEO
Holding Value $1.73M 566,948 shares
Last Trade
Aug 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.92M 109,890 shares
$26.60
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
President & CEO
Holding Value $1.39M 457,058 shares
Last Trade
Apr 30, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 2,987 shares
$38.50
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
President, CEO & Exec Chairman
Holding Value $1.39M 457,058 shares
Last Trade
Apr 30, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 2,987 shares
$38.50
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
Director, President & CEO
Holding Value $915k 300,000 shares
Last Trade
Jan 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.5M 300,000 shares
$71.50
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
President & CEO
Holding Value $1.38M 454,071 shares
Last Trade
Oct 31, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.1k 808 shares
$84.30
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
President & CEO
Holding Value $1.38M 453,263 shares
Last Trade
Apr 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$294k 2,768 shares
$106.20
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
President & CEO
Holding Value $915k 300,000 shares
Last Trade
Nov 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.2M 300,000 shares
$87.40
$3.05
Obalon Therapeutics
Obalon Therapeutics OBLN
President & CEO
Holding Value $0 0 shares
Last Trade
Oct 05, 2016 Sale
No data
No data
$3.05
Dexcom
Dexcom DXCM
President & CEO
Holding Value $214k 2,944 shares
Last Trade
May 02, 2006 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$72.59
Dexcom
Dexcom DXCM
President & CEO
Holding Value $9.29M 127,944 shares
Last Trade
May 02, 2006 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$72.59
Dexcom
Dexcom DXCM
President & CEO
Holding Value $13.9M 191,667 shares
Last Trade
May 02, 2006 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$72.59
Dexcom
Dexcom DXCM
President And CEO
Holding Value $6.73M 92,710 shares
Last Trade
Dec 07, 2005 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$72.59
Dexcom
Dexcom DXCM
President And CEO
Holding Value $0 0 shares
Last Trade
Apr 13, 2005 Sale
No data
No data
$72.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up